Open Access

Poster Session 2 - Beta blockers

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Miscellaneous
Session type: Poster Session
Date: 30 April 2017

Session

6 presentations in this session

Increase of beta-blocker dose and QT interval in heart failure - do we really know it all by heart? Results from CIBIS ELD study.

Speaker: Professor S. Apostolovic (Nis, RS)
Thumbnail

Beneficial effects of beta-blockers and ivabradine combination in patients hospitalized due to worsening of heart failure: findings from

Speaker: Professor Y. Lopatin (Volgograd, RU)
Thumbnail

Are beta-blockers effective in children with congestive heart failure? - A Cochrane review

Speaker: Doctor S. Alabed (Sheffield, GB)
Thumbnail

Quality of life is similar in patients with chronic stable heart failure on vasodilating and non-vasodilating beta blockers.

Speaker: Doctor R. Pharithi (Dublin, IE)
Thumbnail

The impact of 12 month beta-blocker therapy on left and right ventricular volumes and ejection fraction and functional status of heart failure patients with midrange ejection fraction

Speaker: Professor M. Poltavskaya (Moscow, RU)
Thumbnail

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

Speaker: Doctor H. Froehlich (Heidelberg, DE)
Thumbnail

6 speakers from this session

Professor Svetlana Apostolovic

Clinical Center of Nis, Nis (Serbia)
0 follower

Professor Yury Lopatin

Volgograd State Medical University, Volgograd Regional Cardiology Centre, Volgograd (Russian Federation)
15 presentations
0 follower

Doctor Samer Alabed

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Rebabonye Pharithi

Heart Failure Unit, St Vincent University Hospital Group, Dublin (Ireland)
0 follower

Professor Maria Poltavskaya

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)
0 follower

Doctor Hanna Froehlich

University Hospital of Heidelberg, Heidelberg (Germany)
0 follower

This platform is supported by

logo Novo Nordisk